{
  "main_header": {
    "sid": 981259,
    "name": "Sampre Nutrition",
    "stock_name": "Sampre Nutrition",
    "full_name": "Sampre Nutritions Ltd",
    "name_url": "stocks-analysis/sampre-nutrition",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.01",
    "chg": 0.1,
    "chgp": "0.59%",
    "dir": 1,
    "prev_price": "16.91",
    "mcapval": "163.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530617,
    "symbol": "",
    "ind_name": "FMCG",
    "ind_code": 31,
    "indexname": "",
    "isin": "INE375C01022",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "3.34 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sampre-nutrition-981259-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 5502,
    "sid": "981259",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sampre-nutritions-981259"
  },
  "announcements": [
    {
      "caption": "Rumour verification - Regulation 30(11)",
      "datetime": "18-Feb-2026",
      "details": "Submission of clarification under Regulation 30(11) of the SEBI (LODR) Regulations 2015 in respect of information circulating on certain social media platforms. No such combined / joint agreements as alleged has been entered into. Investors are advised to follow the companys filings made only on the stock exchange platforms for verifiable news.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "Publication of the standalone and consolidated unaudited financial statements of the company for the third quarter and nine-month period ended on 31 December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Third Quarter And Nine-Month Period 31 December 2025; With Appointment Of A Non-Executive Non-Independent Additio",
      "datetime": "13-Feb-2026",
      "details": "Board meeting outcome for standalone and consolidated unaudited financial results for the third quarter and nine-month period ended 31 December 2025; with appointment of a non-executive non-independent additional director.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>5:10</strong> stock split, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sampre Nutritions Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 14 Nov 25",
          "dt": "2025-11-14",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News